AI-generated summary
The authors report a 24-week randomized, placebo-controlled trial of home-based tailored light therapy in 61 people with mild cognitive impairment. Compared with placebo light, the active light group showed greater improvement in one memory score and better sleep measures, including less wake after sleep onset. The abstract describes these as group differences in a small trial.
- Participants
- 61
- Who or what was studied
- People living with mild cognitive impairment (mean age 69.7 years in the active light group; 52% male)
- Limits stated in the abstract
- The abstract reports a relatively small sample of 61 participants and does not state wavelengths or light dosing details.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Mild cognitive impairment, Montreal Cognitive Assessment, Placebo-controlled, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.